BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

310 related articles for article (PubMed ID: 37085830)

  • 21. Does restaging MRI radiomics analysis improve pathological complete response prediction in rectal cancer patients? A prognostic model development.
    Chiloiro G; Cusumano D; de Franco P; Lenkowicz J; Boldrini L; Carano D; Barbaro B; Corvari B; Dinapoli N; Giraffa M; Meldolesi E; Manfredi R; Valentini V; Gambacorta MA
    Radiol Med; 2022 Jan; 127(1):11-20. PubMed ID: 34725772
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Combined artificial intelligence and radiologist model for predicting rectal cancer treatment response from magnetic resonance imaging: an external validation study.
    Horvat N; Veeraraghavan H; Nahas CSR; Bates DDB; Ferreira FR; Zheng J; Capanu M; Fuqua JL; Fernandes MC; Sosa RE; Jayaprakasam VS; Cerri GG; Nahas SC; Petkovska I
    Abdom Radiol (NY); 2022 Aug; 47(8):2770-2782. PubMed ID: 35710951
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Predicting Rectal Cancer Response to Total Neoadjuvant Treatment Using an Artificial Intelligence Model Based on Magnetic Resonance Imaging and Clinical Data.
    Ouyang G; Chen Z; Dou M; Luo X; Wen H; Deng X; Meng W; Yu Y; Wu B; Jiang D; Wang Z; Yao Y; Wang X
    Technol Cancer Res Treat; 2023; 22():15330338231186467. PubMed ID: 37431270
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Endorectal ultrasound radiomics in locally advanced rectal cancer patients: despeckling and radiotherapy response prediction using machine learning.
    Abbaspour S; Abdollahi H; Arabalibeik H; Barahman M; Arefpour AM; Fadavi P; Ay M; Mahdavi SR
    Abdom Radiol (NY); 2022 Nov; 47(11):3645-3659. PubMed ID: 35951085
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Radiomic Features of Primary Rectal Cancers on Baseline T
    Antunes JT; Ofshteyn A; Bera K; Wang EY; Brady JT; Willis JE; Friedman KA; Marderstein EL; Kalady MF; Stein SL; Purysko AS; Paspulati R; Gollamudi J; Madabhushi A; Viswanath SE
    J Magn Reson Imaging; 2020 Nov; 52(5):1531-1541. PubMed ID: 32216127
    [TBL] [Abstract][Full Text] [Related]  

  • 26. MRI-Based Radiomic Models Outperform Radiologists in Predicting Pathological Complete Response to Neoadjuvant Chemoradiotherapy in Locally Advanced Rectal Cancer.
    Wen L; Liu J; Hu P; Bi F; Liu S; Jian L; Zhu S; Nie S; Cao F; Lu Q; Yu X; Liu K
    Acad Radiol; 2023 Sep; 30 Suppl 1():S176-S184. PubMed ID: 36739228
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Predicting pathological complete response by comparing MRI-based radiomics pre- and postneoadjuvant radiotherapy for locally advanced rectal cancer.
    Li Y; Liu W; Pei Q; Zhao L; Güngör C; Zhu H; Song X; Li C; Zhou Z; Xu Y; Wang D; Tan F; Yang P; Pei H
    Cancer Med; 2019 Dec; 8(17):7244-7252. PubMed ID: 31642204
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Machine learning classification of texture features of MRI breast tumor and peri-tumor of combined pre- and early treatment predicts pathologic complete response.
    Hussain L; Huang P; Nguyen T; Lone KJ; Ali A; Khan MS; Li H; Suh DY; Duong TQ
    Biomed Eng Online; 2021 Jun; 20(1):63. PubMed ID: 34183038
    [TBL] [Abstract][Full Text] [Related]  

  • 29. MRI-based radiomics of rectal cancer: preoperative assessment of the pathological features.
    Ma X; Shen F; Jia Y; Xia Y; Li Q; Lu J
    BMC Med Imaging; 2019 Nov; 19(1):86. PubMed ID: 31747902
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Prognostic prediction value of the clinical-radiomics tumour-stroma ratio in locally advanced rectal cancer.
    Cai C; Hu T; Rong Z; Gong J; Tong T
    Eur J Radiol; 2024 Jan; 170():111254. PubMed ID: 38091662
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Clinical utility of radiomics at baseline rectal MRI to predict complete response of rectal cancer after chemoradiation therapy.
    Petkovska I; Tixier F; Ortiz EJ; Golia Pernicka JS; Paroder V; Bates DD; Horvat N; Fuqua J; Schilsky J; Gollub MJ; Garcia-Aguilar J; Veeraraghavan H
    Abdom Radiol (NY); 2020 Nov; 45(11):3608-3617. PubMed ID: 32296896
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Image-based artificial intelligence for the prediction of pathological complete response to neoadjuvant chemoradiotherapy in patients with rectal cancer: a systematic review and meta-analysis.
    Shen H; Jin Z; Chen Q; Zhang L; You J; Zhang S; Zhang B
    Radiol Med; 2024 Apr; 129(4):598-614. PubMed ID: 38512622
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Feature selection based on unsupervised clustering evaluation for predicting neoadjuvant chemoradiation response for patients with locally advanced rectal cancer.
    Chen H; Li X; Pan X; Qiang Y; Qi XS
    Phys Med Biol; 2023 Dec; 68(23):. PubMed ID: 37972413
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The MRI radiomics signature can predict the pathologic response to neoadjuvant chemotherapy in locally advanced esophageal squamous cell carcinoma.
    Lu S; Wang C; Liu Y; Chu F; Jia Z; Zhang H; Wang Z; Lu Y; Wang S; Yang G; Qu J
    Eur Radiol; 2024 Jan; 34(1):485-494. PubMed ID: 37540319
    [TBL] [Abstract][Full Text] [Related]  

  • 35. MRI radiomics features of mesorectal fat can predict response to neoadjuvant chemoradiation therapy and tumor recurrence in patients with locally advanced rectal cancer.
    Jayaprakasam VS; Paroder V; Gibbs P; Bajwa R; Gangai N; Sosa RE; Petkovska I; Golia Pernicka JS; Fuqua JL; Bates DDB; Weiser MR; Cercek A; Gollub MJ
    Eur Radiol; 2022 Feb; 32(2):971-980. PubMed ID: 34327580
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Treatment response prediction using MRI-based pre-, post-, and delta-radiomic features and machine learning algorithms in colorectal cancer.
    Shayesteh S; Nazari M; Salahshour A; Sandoughdaran S; Hajianfar G; Khateri M; Yaghobi Joybari A; Jozian F; Fatehi Feyzabad SH; Arabi H; Shiri I; Zaidi H
    Med Phys; 2021 Jul; 48(7):3691-3701. PubMed ID: 33894058
    [TBL] [Abstract][Full Text] [Related]  

  • 37. MRI-based radiomics to predict response in locally advanced rectal cancer: comparison of manual and automatic segmentation on external validation in a multicentre study.
    Defeudis A; Mazzetti S; Panic J; Micilotta M; Vassallo L; Giannetto G; Gatti M; Faletti R; Cirillo S; Regge D; Giannini V
    Eur Radiol Exp; 2022 May; 6(1):19. PubMed ID: 35501512
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Radiomic signature of the FOWARC trial predicts pathological response to neoadjuvant treatment in rectal cancer.
    Zhuang Z; Liu Z; Li J; Wang X; Xie P; Xiong F; Hu J; Meng X; Huang M; Deng Y; Lan P; Yu H; Luo Y
    J Transl Med; 2021 Jun; 19(1):256. PubMed ID: 34112180
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Radiomics Based on DCE-MRI for Predicting Response to Neoadjuvant Therapy in Breast Cancer.
    Zeng Q; Xiong F; Liu L; Zhong L; Cai F; Zeng X
    Acad Radiol; 2023 Sep; 30 Suppl 2():S38-S49. PubMed ID: 37169624
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Radiomics signature as a new biomarker for preoperative prediction of neoadjuvant chemoradiotherapy response in locally advanced rectal cancer.
    Zhang Z; Jiang X; Zhang R; Yu T; Liu S; Luo Y
    Diagn Interv Radiol; 2021 May; 27(3):308-314. PubMed ID: 34003118
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.